VAXXINITY
Aurobindo Pharma's COVID-19 vaccine plan in limbo after partner fails to get EUA in TaiwanAurobindo Pharma on Tuesday said that its COVID-19 vaccine UB-612 programme hasn't progressed, as its partner Vaxxinity failed to secure th...
Aurobindo Pharma channelising efforts to commercialise COVID-19 vaccineDrug major Aurobindo Pharma is looking to commercialise a COVID-19 vaccine, build a portfolio of biosimilar products, expand API production...
- Load More